Notable healthcare headlines for the week: Pfizer, Sanofi, Sarepta Therapeutics and Medtronic in focus
Wall Street’s major averages closed in the green on Friday, and the benchmark S&P 500
Wall Street’s major averages closed in the green on Friday, and the benchmark S&P 500
Grandbrothers/iStock Editorial via Getty Images Johnson & Johnson (NYSE:JNJ) has received FDA approval for its
Sundry Photography/iStock Editorial via Getty Images Johnson & Johnson (NYSE:JNJ) on Friday announced plans to
Gam1983 Cuts to domestic HIV prevention programs reportedly under consideration by HHS could negatively impact
HHS on March 17 filed a brief in a D.C. federal court supporting the agency’s
Rasi Bhadramani Johnson & Johnson (NYSE:JNJ) said on Tuesday that it received U.S. FDA’s Fast
The aggregate spending on U.S. mergers and acquisitions saw a sequential uptick in January, according
narvikk With Wall Street going from record highs to correction territory in a matter of
narvikk Guggenheim has initiated its coverage of psychedelic drug developer Cybin (NYSE:CYBN) with a Buy
Joe Raedle/Getty Images News The Trump administration has decided to withdraw its nominee to lead